Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03118232 · ClinicalTrials.gov registry record · Phase 4
Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization
A Phase 4 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 4
- Development phase
- 13,952
- Enrollment target
NCT03118232 is a Phase 4 study that has completed, run by University of California, Irvine. The registered enrollment target is 13,952 participants.
The verdict
NCT03118232, a Phase 4 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13,952 participants
- Enrollment target
Study Summary
This is a cluster-randomized trial of nursing homes to assess whether decolonization with routine chlorhexidine bathing and periodic use of nasal antiseptics can reduce hospitalizations associated with infections, antibiotic utilization, and multi-drug resistant organism (MDRO) prevalence. The comparator arm will be routine bathing care.
Interventions
- DRUG Chlorhexidine gluconate (CHG)
- DRUG Iodophor (10% povidone-iodine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,952 participants |
| Start Date | 2017-04-03 |
| Est. Completion | 2023-10-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03118232
The ClinicalTrials.gov registry entry for NCT03118232 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13,952 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine gluconate (CHG) is the first listed.
NCT03118232 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03118232 about?
NCT03118232 is a clinical study titled "Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization". This is a cluster-randomized trial of nursing homes to assess whether decolonization with routine chlorhexidine bathing and periodic use of nasal antiseptics can reduce hospitalizations associated with infections, antibiotic utilization, and multi-drug resistant organism (MDRO) prevalence. The compa...
What is the current status of trial NCT03118232?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13,952 participants. The study started on 2017-04-03. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT03118232?
The interventions under investigation include: Chlorhexidine gluconate (CHG) (DRUG), Iodophor (10% povidone-iodine) (DRUG).
Who is sponsoring clinical trial NCT03118232?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.